LGCmain
Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 4588
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size
ORIGINAL ARTICLE
Year : 2015  |  Volume : 58  |  Issue : 2  |  Page : 192-194

Inhibitory-based method for detection of Klebsiella pneumoniae carbapenemase Acinetobacter baumannii isolated from burn patients


1 Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran
2 Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran; Department of Microbiology, Iran University of Medical Sciences, Tehran, Iran
3 Department of Microbiology, Iran University of Medical Sciences, Tehran, Iran
4 Molecular Microbiology Research Center, Tehran, Iran
5 Department of Pathology and Immunology, Washington University School of Medicine, Barnes Jewish Hospital, St. Louis, MO, USA
6 Department of Microbiology, Tehran University of Medical Sciences, Tabriz, Iran
7 Luxembourg University, Faculty of Science Technology and Communication and Liege University, Faculty of Science and Environment, Belgium

Correspondence Address:
Prof. Abdolaziz Rastegar Lari
Department of Microbiology, Iran University of Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0377-4929.155312

Rights and Permissions

Background: Klebsiella pneumoniae carbapenemase (KPC) is one of the carbapenemases that can cause multi-antibiotics resistance in Acinetobacter baumannii. A simple phenotypic rapid and accurate test for the detection of A. baumannii - KPC-producer can be useful in treating related infections. The aim of this study was to determine the synergism effect of boronic acid (BA), as an inhibitor, and meropenem to confirm modified Hodge test (MHT) positive strains for KPC-production. Materials and Methods: Totally, 126 A. baumannii isolates were used as clinical strains. Imipenem resistant isolates were identified by disk diffusion method according to the Clinical Laboratory Standards Institute recommendations. Presence of KPC in imipenem resistant isolates was determined using the MHT. In addition, we used BA as a KPC inhibitor for final confirmation of the species of interest. Additionally, we employed the use of synergism effect of meropenem and cloxacillin to detect false positive cases. Results: Of 126 strains, 108 were resistant to imipenem, for which 93 strains were MHT positive. Totally, 68 out of 93 MHT positive isolates had at least 5 mm enlargement of the diameter of the zone of growth inhibition between the meropenem alone and meropenem combined with BA. Of these 68 isolates, 8 had at least 5 mm enlargement of the diameter of the zone of growth inhibition with BA alone and in 60 strains it was observed by cloxacillin. Conclusion: Our study suggests that MHT alone cannot confirm KPC-producer microorganisms and that it requires other complementary tests such as the usage of inhibitors.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4953    
    Printed93    
    Emailed0    
    PDF Downloaded152    
    Comments [Add]    
    Cited by others 4    

Recommend this journal